How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/recurrent-mucocutaneous-herpes-simplex.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Recurrent Mucocutaneous Herpes Simplex — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Recurrent Mucocutaneous Herpes Simplex (disease) competitive landscape: 3 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

3 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Recurrent Mucocutaneous Herpes Simplex, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Zovirax	ACYCLOVIR	Ligand Pharms	Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]	Purine nucleoside phosphorylase	1982-01-01
Aciclovir	Aciclovir	Assistance Publique Hopitaux De Marseille		Purine nucleoside phosphorylase, DNA polymerase catalytic subunit, Purine nucleoside phosphorylase
ACYC	ACYC	Ligand Pharms		Purine nucleoside phosphorylase, DNA polymerase catalytic subunit, Purine nucleoside phosphorylase

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

Ligand Pharms · 2 drugs in Recurrent Mucocutaneous Herpes Simplex
Assistance Publique Hopitaux De Marseille · 1 drug in Recurrent Mucocutaneous Herpes Simplex

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Recurrent Mucocutaneous Herpes Simplex:

Cite this brief

Drug Landscape (2026). Recurrent Mucocutaneous Herpes Simplex — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/recurrent-mucocutaneous-herpes-simplex. Accessed 2026-06-10.

Recurrent Mucocutaneous Herpes Simplex full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing